Prof Phil Robinson
Prof Phil Robinson
Details
Role
Honorary Fellow Manager
Research area
Infection, Immunity and Global Health
Group
Respiratory
Contact
Available for student supervision
Professor Robinson is the Director of Respiratory and Sleep Medicine at The Royal Children's Hospital. Professor Robinson completed his basic paediatric training at the Royal Children's Hospital before undertaking 3 years of advanced training in Paediatric Respiratory medicine at the Royal Children's before completing 2 years of post-doctoral study at the Pulmonary Research Laboratory of the University of British Columbia in Vancouver, Canada. He was appointed a consultant in Respiratory Medicine at the Royal Children's Hospital in 1991.
He was awarded a PhD from the University of Melbourne in 2003 for his work on the effect of in-utero cigarette smoke exposure on antenatal lung development. He was Director of Cystic Fibrosis (CF) clinical services from 1998 to 2014 helped establish the Royal Children's Cystic Fibrosis Research Trust and remains the Trust's medical chairman. He was the paediatric editor of the first edition of the Australian Standards of Care for Cystic Fibrosis.
In 2014 he established the state's diagnostic service for Primary Ciliary Dyskinesia and an allied clinical bronchiectasis service in 2017. He heads a respiratory drug trial unit that has been involved in over 80 multinational drug trials in the areas of asthma, Cystic Fibrosis, PCD and RSV bronchiolitis. His main area of clinical and research interest is in the area of suppurative lung disease particularly CF and PCD particularly lung imaging of these conditions.
He was awarded a PhD from the University of Melbourne in 2003 for his work on the effect of in-utero cigarette smoke exposure on antenatal lung development. He was Director of Cystic Fibrosis (CF) clinical services from 1998 to 2014 helped establish the Royal Children's Cystic Fibrosis Research Trust and remains the Trust's medical chairman. He was the paediatric editor of the first edition of the Australian Standards of Care for Cystic Fibrosis.
In 2014 he established the state's diagnostic service for Primary Ciliary Dyskinesia and an allied clinical bronchiectasis service in 2017. He heads a respiratory drug trial unit that has been involved in over 80 multinational drug trials in the areas of asthma, Cystic Fibrosis, PCD and RSV bronchiolitis. His main area of clinical and research interest is in the area of suppurative lung disease particularly CF and PCD particularly lung imaging of these conditions.
Professor Robinson is the Director of Respiratory and Sleep Medicine at The Royal Children's Hospital. Professor Robinson completed his basic paediatric training at the Royal Children's Hospital before undertaking 3 years of advanced training in...
Professor Robinson is the Director of Respiratory and Sleep Medicine at The Royal Children's Hospital. Professor Robinson completed his basic paediatric training at the Royal Children's Hospital before undertaking 3 years of advanced training in Paediatric Respiratory medicine at the Royal Children's before completing 2 years of post-doctoral study at the Pulmonary Research Laboratory of the University of British Columbia in Vancouver, Canada. He was appointed a consultant in Respiratory Medicine at the Royal Children's Hospital in 1991.
He was awarded a PhD from the University of Melbourne in 2003 for his work on the effect of in-utero cigarette smoke exposure on antenatal lung development. He was Director of Cystic Fibrosis (CF) clinical services from 1998 to 2014 helped establish the Royal Children's Cystic Fibrosis Research Trust and remains the Trust's medical chairman. He was the paediatric editor of the first edition of the Australian Standards of Care for Cystic Fibrosis.
In 2014 he established the state's diagnostic service for Primary Ciliary Dyskinesia and an allied clinical bronchiectasis service in 2017. He heads a respiratory drug trial unit that has been involved in over 80 multinational drug trials in the areas of asthma, Cystic Fibrosis, PCD and RSV bronchiolitis. His main area of clinical and research interest is in the area of suppurative lung disease particularly CF and PCD particularly lung imaging of these conditions.
He was awarded a PhD from the University of Melbourne in 2003 for his work on the effect of in-utero cigarette smoke exposure on antenatal lung development. He was Director of Cystic Fibrosis (CF) clinical services from 1998 to 2014 helped establish the Royal Children's Cystic Fibrosis Research Trust and remains the Trust's medical chairman. He was the paediatric editor of the first edition of the Australian Standards of Care for Cystic Fibrosis.
In 2014 he established the state's diagnostic service for Primary Ciliary Dyskinesia and an allied clinical bronchiectasis service in 2017. He heads a respiratory drug trial unit that has been involved in over 80 multinational drug trials in the areas of asthma, Cystic Fibrosis, PCD and RSV bronchiolitis. His main area of clinical and research interest is in the area of suppurative lung disease particularly CF and PCD particularly lung imaging of these conditions.
Top Publications
- McCray, G, Griffin, P, Martinello, P, de Iongh, R, Ruddle, J, Robinson, P. Altered airway ciliary orientation in patients with X-linked retinitis pigmentosa. Thorax 74(9) : 914 2019 view publication
- de Vries, L, Griffiths, A, Armstrong, D, Robinson, PJ. Cytokine gene polymorphisms and severity of CF lung disease. Journal of Cystic Fibrosis 13(6) : 699 -705 2014 view publication
- Robinson, P, Schechter, MS, Sly, PD, Winfield, K, Smith, J, Brennan, S, Shinkai, M, Henke, MO, Rubin, BK. Clarithromycin therapy for patients with Cystic Fibrosis: A randomized controlled trial. Pediatric Pulmonology 47(6) : 551 -557 2012 view publication
Career information
Share //
